Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

Antonio Craxi, Vincenza Calvaruso

Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”

Risultato della ricerca: Letter › peer review

25 Citazioni (Scopus)

Lingua originale	English
pagine (da-a)	597-600
Numero di pagine	4
Rivista	Journal of Hepatology
Volume	68
Stato di pubblicazione	Published - 2018

All Science Journal Classification (ASJC) codes

???subjectarea.asjc.2700.2721???

Altri file e collegamenti

OA Link

Cita questo

@article{66d55183e4a343c6865a0c2975a2d0e7,

title = "Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?",

keywords = "HCV, HCV",

author = "Antonio Craxi and Vincenza Calvaruso",

year = "2018",

language = "English",

volume = "68",

pages = "597--600",

journal = "Journal of Hepatology",

issn = "0168-8278",

publisher = "Elsevier",

}

TY - JOUR

T1 - Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

AU - Craxi, Antonio

AU - Calvaruso, Vincenza

PY - 2018

Y1 - 2018

KW - HCV

KW - HCV

UR - http://hdl.handle.net/10447/345373

M3 - Letter

SN - 0168-8278

VL - 68

SP - 597

EP - 600

JO - Journal of Hepatology

JF - Journal of Hepatology

ER -